SCHEMBL6282759

SCHEMBL6282759

CCCCS(=O)(=O)n1cc(/C(C)=N\NC(=N)N)c2cc(Cl)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
KDM1A O60341 3/20 0.33
SLC6A9 P48067 1/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
KCNH2 Q12809 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6282762 1.00 HTR6 (0.35) HTR6KDM4EALDH1A1POLBKDM1A
SCHEMBL6282132 0.90 HTR6 (0.37) HTR6KDM4EALDH1A1SLC6A9CA12
SCHEMBL6282134 0.90 HTR6 (0.37) HTR6KDM4EALDH1A1SLC6A9CA12
SCHEMBL6282816 0.86 SLC6A9 (0.34) HTR6ALDH1A1SLC6A9KCNH2
SCHEMBL6282819 0.86 SLC6A9 (0.34) HTR6ALDH1A1SLC6A9KCNH2
SCHEMBL6282343 0.86 HTR6 (0.47) HTR6CA9MEN1KMT2ASMN1; SMN2
SCHEMBL6282340 0.86 HTR6 (0.47) HTR6CA9MEN1KMT2ASMN1; SMN2
SCHEMBL6281765 0.85 KDM1A (0.36) ALDH1A1KDM1ACA12CA1CA2
SCHEMBL6281767 0.85 KDM1A (0.36) ALDH1A1KDM1ACA12CA1CA2
SCHEMBL6282010 0.83 PTGDR2 (0.37) HTR6ALDH1A1SMN1; SMN2LMNAPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6906095-B2 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2005-06-14 US disclosed
US-20040002527-A1 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands WYETH 2004-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002527-A1 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR2A HTR6 1/4885KDM4E 3802/4885ALDH1A1 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.